ACADIA Pharmaceuticals Reports Third Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. HUM
8. KTOS
9. NVDA
10. CSCO

Go back to ACADIA Pharmaceuticals Reports Third Quarter 2018 Financial Results

Acadia Pharma (ACAD) Tops Q3 EPS by 8c

November 6, 2018 4:09 PM EST

Acadia Pharma (NASDAQ: ACAD) reported Q3 EPS of ($0.50), $0.08 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $58.3 million versus the consensus estimate of $56.31 million.

Guidance:

ACADIA is updating its 2018 NUPLAZID net sales guidance to be between... More